IQVIA Holdings Inc
(STU:QTS)
€
182.05
-0.10 (-0.05%)
Market Cap: 30.42 Bil
Enterprise Value: 42.79 Bil
PE Ratio: 25.72
PB Ratio: 5.57
GF Score: 88/100 IQVIA Holdings Inc at Barclays Global Healthcare Conference Transcript
Mar 16, 2022 / 05:35PM GMT
Release Date Price:
€197.7
(+1.13%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst
Good afternoon, everyone. My name is Luke Sergott. I cover life sciences tools and diagnostics at Barclays. It's my pleasure to introduce, this as not Ron, it's Mike Fedock. He's the Head of FP&A from -- and former CFO of the RDS business at IQVIA; and Nick Childs. Ron was sick today. So Mike's subbing in.
Michael Fedock
IQVIA Holdings Inc. - SVP of Financial Planning and Analysis
Yes. It was hard to express my dedication to IQVIA to agree upon to South Florida on short notice, but that's the sacrifices I make for Ron and Ari.
Questions & Answers
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst
All right. That's great. So I guess, as I've been doing with everybody else, let's just dive right into the macro here, go through -- let's start with the Ukraine-Russia invasion. Anything that you're seeing there from a demand perspective, any knock-on effects for trials, things like that?
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot